Summary:
-
-
- The global infant phototherapy devices market size reached USD 89.4 Million in 2023.
- The market is expected to reach USD 123.2 Million by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.
- Based on the region, the market has been segmented into North America (United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
- Based on the light source, the market has been divided into fluorescent lamps (FL), light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes.
- Based on the configuration, the market has been categorized into mobile device and fixed device.
- On the basis of end-user, the market has been bifurcated into hospital and neonatal clinics.
- The rising incidence of neonatal jaundice is a primary driver of the infant phototherapy devices market.
- Technological advancements and the introduction of portable and wearable phototherapy devices are reshaping the infant phototherapy devices market.
-
Request to Get the Sample Report: https://www.imarcgroup.com/infant-phototherapy-devices-market/requestsample
Industry Trends and Drivers:
- Rising Incidence of Neonatal Jaundice:
The growing prevalence of neonatal jaundice is one of the major factors propelling the market growth. Moreover, the increasing incidence of premature births, maternal health conditions like diabetes, and certain genetic traits that contribute to the rising cases of neonatal jaundice are fostering the market growth.
Besides this, the heightened focus of healthcare systems on early detection and treatment, boosting the adoption of phototherapy as the standard method for managing jaundice in newborns, is catalyzing the market growth. Apart from this, the growing investment by hospitals and neonatal care centers in advanced phototherapy devices to offer effective and non-invasive treatment, thus improving clinical outcomes for infants, is favoring the market growth.
- Rapid Technological Advancements in Phototherapy Devices:
The ongoing technological innovations that enhance the safety, efficiency, and convenience of treatment are anticipated to drive the market growth. Along with this, the introduction of devices equipped with light-emitting diodes (LEDs) that offer several advantages, including longer lifespan, reduced heat emission, and energy efficiency, is fueling the market growth. They also provide more targeted wavelengths of light, which improves treatment efficacy while minimizing the risk of burns or dehydration in infants.
Furthermore, rapid advancements in portable and wearable phototherapy devices that create new opportunities in home healthcare are catalyzing the market growth. These devices enable parents to treat infants at home while maintaining the same level of care as in hospital settings.
- Growing Healthcare Expenditure and Neonatal Care Facilities:
The increasing healthcare expenditure that fuels the expansion of neonatal care facilities is driving the market growth. Moreover, the growing investment by governments and private healthcare providers in modern medical infrastructure to enhance neonatal care and reduce infant mortality rates is bolstering the market growth.
Along with this, the establishment of specialized neonatal intensive care units (NICUs) to provide comprehensive care for newborns, including those suffering from jaundice, is fueling the market growth. Besides this, the rising focus on improving healthcare access and quality in low- and middle-income countries, resulting in higher procurement rates for infant phototherapy devices, is enhancing the market growth.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=4728&flag=C
Infant Phototherapy Devices Market Report Segmentation:
Breakup By Light Source:
- Fluorescent Lamps (FL)
- Light-Emitting Diodes (LEDs)
- Quartz Halogen Lamps
- Gas Discharge Tubes
Based on the light source, the market has been divided into fluorescent lamps (FL), light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes.
Breakup By Configuration:
- Mobile Device
- Fixed Device
Based on the configuration, the market has been categorized into mobile device and fixed device.
Breakup By End User:
- Hospital
- Neonatal Clinics
On the basis of end-user, the market has been bifurcated into hospital and neonatal clinics.
Breakup By Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Based on the region, the market has been segmented into North America (United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
Top Infant Phototherapy Devices Market Leaders: The infant phototherapy devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.
Some of the key players in the market are:
- Atom Medical Corporation
- AVI Healthcare Private Limited
- Equalize Health
- General Electric Company
- Ibis Medical Equipment and Systems Pvt Ltd
- Natus Medical Incorporated
- Ningbo David Medical Device Company Limited
- NOVOS Medical Systems
- Weyer GmbH
- Zhengzhou Dison Instrument
- Meter Co. Ltd.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1–631–791–1145